Science Explorer Interactive view Map
Company · Rockville · United States

OncoImmune (United States)

oncoimmune.comROR OpenAlex
Research works
67
▲ 302% vs 2013–17
Citations
1.6k
23.8 per fractional work
Top-10% rate
7.5%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: OncoImmune (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.81× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 21.68× its world share, 4 worksImmunology and Micro…Chemistry: 1.70× its world share, 0 worksChemistryEngineering: 0.24× its world share, 1 worksEngineeringMaterials Science: 0.51× its world share, 0 worksMaterials ScienceMedicine: 1.90× its world share, 7 worksMedicineArts and Humanities: 0.92× its world share, 0 worksArts and Humanities1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 21.7×. Every wedge is a field page.

Which keywords describe research at OncoImmune (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Antigen Presentation, Innate Immunity, Dendritic Cells, Tumor Antigen, Vaccine Adjuvants and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy9▲ 100×3 topics
  2. Immunity9▲ 38×5 topics
  3. Antigen Presentation8▲ 114×2 topics
  4. Innate Immunity8▲ 32×4 topics
  5. Dendritic Cells7▲ 88×2 topics
  6. Tumor Antigen7▲ 124×1 topic
  7. Vaccine Adjuvants7▲ 124×1 topic
  8. Tumor Microenvironment6▲ 27×6 topics
  9. Immunotherapy6▲ 14×8 topics
  10. Immune Checkpoint Blockade5▲ 142×1 topic
  11. PD-1 and PD-L15▲ 142×1 topic
  12. Glycosylation5▲ 35×2 topics
  13. Cancer5▲ 5.3×13 topics
  14. Inflammation5▲ 3.0×16 topics
  15. Fc Receptors4▲ 60×1 topic
  16. Therapeutic Antibodies4▲ 46×1 topic
  17. Cancer Therapy4▲ 8.4×9 topics
  18. Chemotherapy4▲ 7.6×7 topics
  19. Targeted Therapy3▲ 22×5 topics
  20. Autoimmunity3▲ 22×4 topics
  21. Gene Therapy3▲ 17×4 topics
  22. NK Cell Recognition3▲ 42×1 topic
  23. Natural Killer Cells3▲ 42×1 topic
  24. Tumor Regression3▲ 49×2 topics
  25. Nanoparticles3▲ 3.2×3 topics
  26. Lymphoma3▲ 27×2 topics
  27. Metastasis3▲ 12×4 topics
  28. CAR T Cells3▲ 87×1 topic
  29. Chimeric Antigen Receptor3▲ 87×1 topic
  30. TGF-ß3▲ 23×2 topics
  31. Angiogenesis2▲ 9.1×4 topics
  32. CD4+CD25+2▲ 50×1 topic
  33. Foxp32▲ 50×1 topic
  34. Prognostic Factors2▲ 7.6×7 topics
  35. RNA Interference2▲ 28×1 topic
  36. siRNA Delivery2▲ 42×1 topic
  37. Reactive Oxygen Species2▲ 6.1×5 topics
  38. Self-Assembly2▲ 7.5×2 topics
  39. Apoptosis2▲ 6.8×5 topics
  40. Extracellular Matrix2▲ 10×2 topics

Which research topics does OncoImmune (United States) publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and RNA Interference and Gene Delivery.

Immunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksRNA Interference and Gen…1RNA Interference and Gene Delivery: 1 fractional worksAdvanced biosensing and bioanalysis techniques: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksDNA and Nucleic Acid Che…1DNA and Nucleic Acid Chemistry: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksNanoplatforms for cancer theranostics: 1 fractional worksUbiquitin and proteasome pathways: 1 fractional works
ImmunologyOncologyMolecular BiologyRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 2 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 RNA Interference and Gene Delivery Molecular Biology 1 works
  5. 5 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 DNA and Nucleic Acid Chemistry Molecular Biology 1 works
  8. 8 Immune Cell Function and Interaction Immunology 1 works
  9. 9 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  10. 10 Ubiquitin and proteasome pathways Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.9%not open62.1%

World: 28% of research is openly available.

with international co-authors15.2%domestic only84.8%

World: 19% is written across borders.

How has OncoImmune (United States)'s research output changed?

Output in 2018–2022 was 302% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rockville

All research institutions in Rockville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.